Research Article
The Effects of Uric Acid, Serum Vitamin D3, and Their Interaction on Parkinson’s Disease Severity
Table 1
The mean values of uric acid level, vitamin D3 level, and UPDRS score in total study sample and in different age and sex groups.
| | UA (mg/dL) | value | Serum vitamin D3 (ng/mL) | value | Duration (month) | value | UPDRS | value |
| Total sample | 5.45 + 1.54 | — | 28.47 + 14.24 | — | 56.61 + 40.8 | — | 23.09 + 17.86 | — | Age (year) | | | | | | | | | ≤62 | 5.32 ± 1.70 | 0.377 | 24.82 ± 12.32 | 0.008 | 52.22 ± 43.09 | 0.401 | 19.21 ± 18.06 | 0.017 | >62 | 5.57 ± 1.38 | 32.14 ± 16.15 | 61.00 ± 38.51 | 26.98 ± 17.64 | Sex | | | | | | | | | Male | 5.53 ± 1.33 | 0.354 | 28.68 ± 14.57 | 0.604 | 56.16 ± 47.34 | 0.686 | 24.30 ± 18.84 | 0.251 | Female | 5.25 ± 1.94 | 27.10 ± 14.94 | 60.02 ± 54.54 | 20.29 ± 16.76 |
|
|
UPDRS: Unified Parkinson’s Disease Rating Scale III; UA: uric acid. All presented value resulted from independent samples -test or Mann-Whitney test.
|